NAMPT and neoplasm: In recent years, several NAMPT inhibitors have been described, (GNE-617 [6]; APO866[7], GMX1778 [8]; reviewed by Montecucco et al [9]) and as expected, inhibiting NAMPT leads to depletion of NAD and tumor growth inhibition both in vitro and in vivo.